Using Digital Pathology to Accelerate Preclinical R&D
about
Preclinical research and development (R&D) centers around workflows that generate more pathology data than any other phase of drug discovery and development. Leading pharmaceutical companies, biotechnology companies, and CROs are rapidly adopting digital pathology to drive efficiency and quality gains while capitalizing on the promise of their data.
In this webinar, Nathan Buchbinder, co-founder and Chief Product Officer of Proscia, a leader in digital and computational pathology, will share insights on how digital pathology is advancing preclinical R&D to streamline routine operations, improve the reproducibility of their results, and better leverage their pathology data. During this engaging session, you will explore:
- How digital and computational pathology are addressing common pain points in preclinical R&D, such as lengthy timelines, and high study costs for GLP-compliant as well as non-regulated research and development
- Real-world use case examples of how leading life sciences organizations are modernizing their routine workflows to drive quality and efficiency including toxpath scoring and peer review workflows
- The impact of AI and computational applications in delivering ROI and capitalizing on digitized pathology data
- The technology that’s enabling life sciences organizations to realize these benefits in practice, and strategies and key considerations to make the most of digital pathology adoption for preclinical studies and beyond.
Whether you’re a researcher, a pathologist, or simply interested in the latest technology trends in the life sciences, this webinar is not to be missed.
Keywords: Drug Safety, Pathology, AI, Digital Pathology, Pre-Clinical
Speaker
Nathan Buchbinder, Co-Founder & Chief Product Officer, Proscia
Nathan Buchbinder is co-founder and Chief Product Officer at Proscia, a leader in digital and computational pathology solutions, where he drives strategy and innovation for the company’s platform and AI product lines. Under his direction, Proscia’s digital pathology platform has powered a complete modernization for leading life sciences organizations and diagnostic laboratories. Nathan holds a bachelor’s degree in biomedical engineering from Johns Hopkins University and a master’s degree in biomedical innovation and development from the Georgia Institute of Technology.
Who Should Attend?
This webinar is ideal for researchers, pathologists, and laboratory personnel working in preclinical research and development. It is also suitable for professionals in pharmaceutical and biotech companies, CROs, and other life sciences organizations interested in the latest trends and technologies in digital pathology. Whether you’re a decision-maker considering the adoption of digital pathology technologies or simply interested in learning more about this exciting field, this webinar offers valuable insights into how digital pathology can help advance preclinical R&D and improve the quality and efficiency of pathology workflows.
What You Will Learn
Attendees will learn:
- Find out how digital and computational pathology are transforming preclinical R&D by streamlining routine operations, improving result reproducibility, and better leveraging pathology data.
- Explore real-world use cases and examples of how leading life sciences organizations are modernizing their workflows to drive quality and efficiency gains using digital pathology.
- Gain insights into the impact of AI and computational applications on delivering ROI and maximizing the potential of digitized pathology data.
- Discover key considerations and strategies for adopting digital pathology in preclinical studies, including how to address common pain points and achieve long-term success.
Comments are closed.